Raw Materials for Cell & Gene Therapy: Getting it Right from the Start

As the cell and gene therapy sector matures, the requirement for robust and high quality supply of GMP-compliant raw and ancillary materials becomes more and more of an imperative. This spotlight looks at the key current issues with a focus on real-world experiences:
  • Donor screening and selection
  • Optimizing raw materials at source: key considerations for the safe collection and processing of cell source material
  • Characterization of raw materials: identity, purity and functionality testing
  • Understanding the regulatory requirements